Statement of Changes in Beneficial Ownership (4)
August 27 2021 - 5:46PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
LACORTE BLAIR |
2. Issuer Name and Ticker or Trading Symbol
CF Finance Acquisition Corp. III
[
LIDR
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Chief Executive Officer |
(Last)
(First)
(Middle)
13063 VENTURA BLVD |
3. Date of Earliest Transaction
(MM/DD/YYYY)
8/16/2021 |
(Street)
STUDIO CITY, CA 916042238
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock | 8/16/2021 | | A | | 1405484 | A | $37.2080 (1) | 1405484 | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Stock Option (Right to Buy) | $7.0008 | 8/16/2021 | | A | | 77519 | | 8/16/2021 (2) | 5/31/2027 | Common Stock | 77519 | $37.2080 (2) | 77519 | D | |
Stock Option (Right to Buy) | $7.0008 | 8/16/2021 | | A | | 19382 | | 8/16/2021 (3) | 5/7/2028 | Common Stock | 19382 | $37.2080 (3) | 19382 | D | |
Stock Option (Right to Buy) | $7.0008 | 8/16/2021 | | A | | 30362 | | 8/16/2021 (4) | 9/17/2028 | Common Stock | 30362 | $37.2080 (4) | 30362 | D | |
Stock Option (Right to Buy) | $7.0008 | 8/16/2021 | | A | | 108525 | | 8/16/2021 (5) | 2/27/2029 | Common Stock | 108525 | $37.2080 (5) | 108525 | D | |
Stock Option (Right to Buy) | $7.0008 | 8/16/2021 | | A | | 20930 | | 8/16/2021 (6) | 7/1/2029 | Common Stock | 20930 | $37.2080 (6) | 20930 | D | |
Stock Option (Right to Buy) | $7.0008 | 8/16/2021 | | A | | 30481 | | 8/16/2021 (7) | 4/9/2030 | Common Stock | 30481 | $37.2080 (7) | 30481 | D | |
Stock Option (Right to Buy) | $7.0008 | 8/16/2021 | | A | | 6497789 | | 8/16/2021 (8) | 9/30/2030 | Common Stock | 6497789 | $37.2080 (8) | 6497789 | D | |
Stock Option (Right to Buy) | $7.0008 | 8/16/2021 | | A | | 11162 | | 8/16/2021 (9) | 4/5/2031 | Common Stock | 11162 | $37.2080 (9) | 11162 | D | |
Explanation of Responses: |
(1) | Received in exchange for 377,737 shares of AEye Technologies, Inc. ("AEye Technologies") in connection with the merger of AEye Technologies into AEye, Inc. (the "Company") pursuant to the exchange ratio set forth in the Agreement and Plan of Merger between AEye Technologies and the Company. The closing price of the Company's Common Stock on the effective date of the merger was $37.2080 |
(2) | Received in exchange for stock options to acquire 20,834 shares of AEye Technologies, Inc. ("AEye Technologies") in connection with the merger of AEye Technologies into AEye, Inc. (the "Company") pursuant to the exchange ratio set forth in the Agreement and Plan of Merger between AEye Technologies and the Company. The closing price of the Company's Common Stock on the effective date of the merger was $37.2080. These stock options are fully vested. |
(3) | Received in exchange for stock options to acquire 5,209 shares of AEye Technologies, Inc. ("AEye Technologies") in connection with the merger of AEye Technologies into AEye, Inc. (the "Company") pursuant to the exchange ratio set forth in the Agreement and Plan of Merger between AEye Technologies and the Company. The closing price of the Company's Common Stock on the effective date of the merger was $37.2080. These stock options are fully vested. |
(4) | Received in exchange for stock options to acquire 8,160 shares of AEye Technologies, Inc. ("AEye Technologies") in connection with the merger of AEye Technologies into AEye, Inc. (the "Company") pursuant to the exchange ratio set forth in the Agreement and Plan of Merger between AEye Technologies and the Company. The closing price of the Company's Common Stock on the effective date of the merger was $37.2080. These stock options are partially vested and will fully vest on September 18, 2022. |
(5) | Received in exchange for stock options to acquire 29,167 shares of AEye Technologies, Inc. ("AEye Technologies") in connection with the merger of AEye Technologies into AEye, Inc. (the "Company") pursuant to the exchange ratio set forth in the Agreement and Plan of Merger between AEye Technologies and the Company. The closing price of the Company's Common Stock on the effective date of the merger was $37.2080. These stock options are partially vested and will fully vest on January 1, 2023. |
(6) | Received in exchange for stock options to acquire 5,625 shares of AEye Technologies, Inc. ("AEye Technologies") in connection with the merger of AEye Technologies into AEye, Inc. (the "Company") pursuant to the exchange ratio set forth in the Agreement and Plan of Merger between AEye Technologies and the Company. The closing price of the Company's Common Stock on the effective date of the merger was $37.2080. These stock options are partially vested and will fully vest on March 18, 2023. |
(7) | Received in exchange for stock options to acquire 8,192 shares of AEye Technologies, Inc. ("AEye Technologies") in connection with the merger of AEye Technologies into AEye, Inc. (the "Company") pursuant to the exchange ratio set forth in the Agreement and Plan of Merger between AEye Technologies and the Company. The closing price of the Company's Common Stock on the effective date of the merger was $37.2080. These stock options are fully vested. |
(8) | Received in exchange for stock options to acquire 1,746,342 shares of AEye Technologies, Inc. ("AEye Technologies") in connection with the merger of AEye Technologies into AEye, Inc. (the "Company") pursuant to the exchange ratio set forth in the Agreement and Plan of Merger between AEye Technologies and the Company. The closing price of the Company's Common Stock on the effective date of the merger was $37.2080. These stock options are partially vested and will fully vest on December 10, 2023. |
(9) | Received in exchange for stock options to acquire 3,000 shares of AEye Technologies, Inc. ("AEye Technologies") in connection with the merger of AEye Technologies into AEye, Inc. (the "Company") pursuant to the exchange ratio set forth in the Agreement and Plan of Merger between AEye Technologies and the Company. The closing price of the Company's Common Stock on the effective date of the merger was $37.2080. These stock options are partially vested and will fully vest on February 16, 2022. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
LACORTE BLAIR 13063 VENTURA BLVD STUDIO CITY, CA 916042238 | X |
| Chief Executive Officer |
|
Signatures
|
/s/ Blair LaCorte | | 8/27/2021 |
**Signature of Reporting Person | Date |
AEye (NASDAQ:LIDR)
Historical Stock Chart
From Mar 2024 to Apr 2024
AEye (NASDAQ:LIDR)
Historical Stock Chart
From Apr 2023 to Apr 2024